Latest Regulatory Compliance News

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.

Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.

Auking Mining’s planned acquisition of Orion Resources has hit a regulatory roadblock, while Orion’s purchase of the Cloncurry Gold Project assets faces settlement delays due to vendor conditions.

SportsHero Limited has voluntarily suspended trading on the ASX pending a Supreme Court decision regarding its failure to lodge required cleansing notices for recent share issues.

Encounter Resources has completed the first tranche of its $25 million share placement, raising approximately $24.5 million to advance its mineral exploration projects. The second tranche, involving shares to a company director, awaits shareholder approval.

Mount Hope Mining has issued over six million shares via placement and is set to offer additional shares through a share purchase plan, signaling a strategic capital raise.

Bentley Capital Limited is poised to lift its trading suspension on 6 November 2025 following a key announcement addressing legal costs and regulatory queries.

Sweden’s Parliament has voted to overturn its uranium mining ban, effective January 2026, paving the way for Aura Energy to fully develop its polymetallic Häggån project with uranium extraction now permitted.

Arafura Rare Earths secures an ASX waiver allowing eligible shareholders to vote on its upcoming Share Purchase Plan, ensuring broader participation in a key capital raising step.

QBE Insurance Group has priced a $300 million issue of USD subordinated notes due in 2037, offering investors a fixed 5.239% interest rate initially, with a reset in 2032 tied to U.S. Treasury yields. These notes strengthen QBE’s regulatory capital under APRA’s framework.

PEXA Group reported a robust first quarter for FY26, driven by refinancing growth in Australia and rising momentum in the UK market. The company reaffirmed its full-year guidance while advancing key strategic initiatives including platform modernization and a NatWest partnership.